Welcome Guest
Home > Clinical Lymphoma & Myeloma > Volume 4 | Supplement 1

Table of Contents

Volume 4 | Supplement 1

Publication Date: August 2003
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Introduction
Page Number of this Article in the Print Version
S4		 Introduction
Vinay K. Jain
  • Abstract
  • No Access
  • Add to Cart
Contributions
Page Number of this Article in the Print Version
S5-S12		 Overview of Antibody Therapy in B-Cell Non-Hodgkin’s Lymphoma
Luciano Wannesson, Michele Ghielmini
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S13-S17		 Epoetin Alfa Therapy for Patients with Hematologic Malignancies and Mild Anemia
David J. Straus
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S18-S22		 Pegylated Liposomal Doxorubicin, Vincristine, and Reduced-Dose Dexamethasone as First-Line Therapy for Multiple Myeloma
Mohamad Hussein
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S23-S29		 The Implications of Anemia in Multiple Myeloma
Moshe Mittelman
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S30-S35		 Farnesyltransferase Inhibitors in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Jorge Cortes
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S36-S40		 The Role of Erythropoietin in the Anemia of Myelodysplastic Syndrome
Richard S. Stein
  • Abstract
  • No Access
  • Add to Cart